GlaxoSmithkline profits rise

Bengaluru (IANS) GlaxoSmithkline Consumer Healthcare Ltd (GSK) on Wednesday reported a net profit of Rs.155 crore for the first quarter of fiscal 2015-16, an increase of 19.12 percent from the same quarter of fiscal 2014-15.

According to the standalone unaudited results for the quarter that ended on June 30, GSK’s profits rose by Rs.24.88 crore compared to Q1 2014-15. It registered profits of Rs.130.12 crore in the year ago quarter.

GSK’s total income for the April-June quarter of the current fiscal grew by 8.71 percent at Rs.1,099.92 crore, compared to Rs.1011.73 crore of Q1 2014-15, a rise of Rs.88.19 crore.

Earnings per share before extraordinary items and after extraordinary items of the pharmaceutical company remained the same, it rose from Rs.30.94 to Rs.36.85 on a quarter-on-quarter basis.

Established in India in 1924, the Bengaluru-based pharmaceutical company’s product portfolio includes prescription medicines and vaccines.

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.